HK1042896A1 - 吡啶並吡嗪化合物的新的鹽及其結晶 - Google Patents
吡啶並吡嗪化合物的新的鹽及其結晶Info
- Publication number
- HK1042896A1 HK1042896A1 HK02104375.5A HK02104375A HK1042896A1 HK 1042896 A1 HK1042896 A1 HK 1042896A1 HK 02104375 A HK02104375 A HK 02104375A HK 1042896 A1 HK1042896 A1 HK 1042896A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- crystals
- novel salts
- pyridopyrazine
- compound
- pyridopyrazine compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP27444098 | 1998-09-29 | ||
PCT/JP1999/005182 WO2000018768A1 (fr) | 1998-09-29 | 1999-09-22 | Nouveaux sels d'un compose de pyridopyrazine et cristaux desdits sels |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1042896A1 true HK1042896A1 (zh) | 2002-08-30 |
Family
ID=17541719
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK02104375.5A HK1042896A1 (zh) | 1998-09-29 | 2002-06-11 | 吡啶並吡嗪化合物的新的鹽及其結晶 |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP1118615A4 (zh) |
KR (1) | KR20010075287A (zh) |
CN (1) | CN1328555A (zh) |
AU (1) | AU5758199A (zh) |
BR (1) | BR9914399A (zh) |
CA (1) | CA2345362A1 (zh) |
CZ (1) | CZ20011164A3 (zh) |
HK (1) | HK1042896A1 (zh) |
HU (1) | HUP0103947A3 (zh) |
IL (1) | IL142147A0 (zh) |
TR (2) | TR200200971T2 (zh) |
WO (1) | WO2000018768A1 (zh) |
ZA (1) | ZA200102566B (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MY140561A (en) | 2002-02-20 | 2009-12-31 | Nycomed Gmbh | Dosage form containing pde 4 inhibitor as active ingredient |
EP1511516B1 (en) * | 2002-05-28 | 2008-12-17 | Nycomed GmbH | Topically applicable pharmaceutical preparation |
JP2006501269A (ja) * | 2002-09-16 | 2006-01-12 | アルコン マニュファクチャリング,リミティド | 血管新生を処置するためのpdeivインヒビターの使用 |
EA009985B1 (ru) | 2003-03-10 | 2008-04-28 | Никомед Гмбх | Новый способ получения рофлумиласта |
CA2601250C (en) | 2005-03-16 | 2014-10-28 | Nycomed Gmbh | Taste masked dosage form containing roflumilast |
KR20120073300A (ko) * | 2009-09-30 | 2012-07-04 | 뗑따마르 에스아에스 | 휴대 가방 또는 조끼 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0008864A1 (en) * | 1978-08-15 | 1980-03-19 | FISONS plc | Pyridopyrazine and quinoxaline derivatives, processes for their preparation, and pharmaceutical compositions containing them |
AU594512B2 (en) * | 1986-09-16 | 1990-03-08 | Merck Patent Gesellschaft Mit Beschrankter Haftung | Hydroxy indole derivatives |
GB9413975D0 (en) * | 1994-07-11 | 1994-08-31 | Fujisawa Pharmaceutical Co | New heterobicyclic derivatives |
-
1999
- 1999-09-22 TR TR2002/00971T patent/TR200200971T2/xx unknown
- 1999-09-22 WO PCT/JP1999/005182 patent/WO2000018768A1/ja not_active Application Discontinuation
- 1999-09-22 AU AU57581/99A patent/AU5758199A/en not_active Abandoned
- 1999-09-22 BR BR9914399-2A patent/BR9914399A/pt not_active IP Right Cessation
- 1999-09-22 KR KR1020017003667A patent/KR20010075287A/ko not_active Application Discontinuation
- 1999-09-22 CA CA002345362A patent/CA2345362A1/en not_active Abandoned
- 1999-09-22 IL IL14214799A patent/IL142147A0/xx unknown
- 1999-09-22 EP EP99944776A patent/EP1118615A4/en not_active Withdrawn
- 1999-09-22 CN CN99813617A patent/CN1328555A/zh active Pending
- 1999-09-22 HU HU0103947A patent/HUP0103947A3/hu unknown
- 1999-09-22 TR TR2001/00893T patent/TR200100893T2/xx unknown
- 1999-09-22 CZ CZ20011164A patent/CZ20011164A3/cs unknown
-
2001
- 2001-03-28 ZA ZA200102566A patent/ZA200102566B/en unknown
-
2002
- 2002-06-11 HK HK02104375.5A patent/HK1042896A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
CN1328555A (zh) | 2001-12-26 |
WO2000018768A1 (fr) | 2000-04-06 |
EP1118615A4 (en) | 2002-02-27 |
BR9914399A (pt) | 2002-01-22 |
ZA200102566B (en) | 2002-07-18 |
CA2345362A1 (en) | 2000-04-06 |
HUP0103947A3 (en) | 2002-06-28 |
KR20010075287A (ko) | 2001-08-09 |
HUP0103947A2 (hu) | 2002-04-29 |
IL142147A0 (en) | 2002-03-10 |
EP1118615A1 (en) | 2001-07-25 |
AU5758199A (en) | 2000-04-17 |
TR200100893T2 (tr) | 2001-11-21 |
CZ20011164A3 (cs) | 2001-12-12 |
TR200200971T2 (tr) | 2002-06-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HU9900592D0 (en) | Compound and its use | |
GB0119695D0 (en) | Novel compound | |
PL346544A1 (en) | Crystalline forms of eto2 | |
EP1056455A4 (en) | EPIMORPHIN COMPOUND AND USE OF THE SAME | |
GB9805348D0 (en) | Compound | |
GB9805644D0 (en) | Superconducting tapes | |
GB9906632D0 (en) | Leaderless tape drive | |
IL125271A0 (en) | Head of line blocking | |
GB9805646D0 (en) | Superconducting tapes | |
AU139511S (en) | Cassette | |
HK1042896A1 (zh) | 吡啶並吡嗪化合物的新的鹽及其結晶 | |
PL342295A1 (en) | Paroxetin salts | |
GB9827431D0 (en) | Novel compound | |
PL318937A1 (en) | Spirostanyloglycoside crystals | |
IL140766A0 (en) | Novel salts of n-tert-butylhydroxylamine | |
GB9808268D0 (en) | Compound | |
GB9927927D0 (en) | Compound composition and use | |
GB9805641D0 (en) | Superconducting tapes | |
IL163513A0 (en) | A composition containing a tnf-2-converting enzymepolypeptidein crystalline form and methods for thepreparation thereof | |
GB9828427D0 (en) | Liquid crystalline trifluoro-substituted compounds | |
GB9808896D0 (en) | Novel compound | |
AU3960700A (en) | Triazolopyrimidinol compounds and salts thereof | |
GB9808894D0 (en) | Novel compound | |
GB9823175D0 (en) | Compound | |
SI1107980T1 (en) | CRYSTALLINE FORMS OF EtO2C-CH2-(R)Cgl-Aze-Pab-OH |